Skip to main content

#161691

Anti-CD42a monoclonal antibody [GR-P]

Cat. #161691

Anti-CD42a monoclonal antibody [GR-P]

Cat. #: 161691

Sub-type: Primary antibody

Availability: 3-4 weeks

Target: GR-P

Class: Monoclonal

Application: FACS; IHC; ELISA; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Francisco Ruíz-Cabello Osuna, Miguel Ángel López-Nevot and Federico Garrido Torres-Puchol

Institute: Virgen de las Nieves University Hospital, The Andalusian Health Service

Primary Citation: Knapp et al. 1989. The Journal of Pathology. ISBN: 0192618679

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CD42a monoclonal antibody [GR-P]
  • Cancer: Blood cancer
  • Research fields: Cancer
  • Clone: GR-P
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Molecular weight: 23 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS; IHC; ELISA; WB
  • Description: CD42a antigen (GPIX) is a glycoprotein that forms a complex with non-covalently bound GPIb. This antigen is primarily expressed by platelets and megakaryocytes
  • Immunogen: B-ALL cells
  • Isotype: IgG1
  • Recommended controls: Platelets, megaKariocytes

Target Details

  • Target: GR-P
  • Target alternate names: CD42a
  • Molecular weight: 23 kDa

Applications

  • Application: FACS; IHC; ELISA; WB

Handling

  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Knapp et al. 1989. The Journal of Pathology. ISBN: 0192618679

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.